跳至主要内容
临床试验/NCT02947191
NCT02947191Unknown1 期

The Safety and Efficacy Assessment of Collagen Membrane Combined With Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Patients With Nasal Septum Perforation

Chinese Academy of Sciences1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2016年11月最近更新:
适应症

试验速览

阶段
1 期
入组人数
12
试验地点
1
主要终点
The change of integrity of nasal septum assessed by endoscopic examination

研究概览

简要总结

The purpose of this study is to assess the safety and efficacy of collagen membrane combined with human clinical grade umbilical cord mesenchymal stem cells(HUC-MSCs) transplantation in patients with chronic nasal septum perforation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with nasal septum perforation area less than 1cm², and requires minimally-invasive treatment.
  • Male or female, 18-45 years old.
  • Ability and willingness to regular visit to hospital and follow up during the protocol Procedures.

排除标准

  • Cystic fibrosis, immotile cilia syndrome and other genetic diseases.
  • Syphilis, leprosy, tuberculosis and other specific infections.
  • Severe Sinusitis.
  • Autoimmune diseases or long term treatment with corticosteroids.
  • Alzheimer's disease.
  • Systemic diseases (e.g.,hypertension, diabetes and so on).
  • Previous history of nasal cancer or after receiving radiotherapy.
  • Drug abuse.
  • History of mental illness.

结局指标

主要结局

The change of integrity of nasal septum assessed by endoscopic examination

时间窗: baseline, 1,2,3,4,8,12 weeks after surgery

次要结局

  • The change of nasal obstructive symptom assessed by visual analogue scale (VAS)(baseline, 12 weeks after surgery)
  • The change of nasal symptom severity assessed by total nasal symptom score (TNSS)(baseline, 12 weeks after surgery)
  • The change of nasal mucosal physiology assessed by nasal mucociliary clearance time (MCT)(baseline, 12 weeks after surgery)
  • The change of nasal airway resistance assessed by rhinomanometry(baseline, 12 weeks after surgery)
  • The change of nasal obstruction assessed by acoustic rhinometry(baseline, 12 weeks after surgery)
  • Change from baseline in computed tomography (CT)(baseline, 12 weeks after surgery)
  • The change of nasal mucosal physiology assessed by olfactory test(baseline, 12 weeks after surgery)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Jianwu Dai

Principal Investigator of Regenerative Medicine Laboratory, Institute of Genetics and Developmental Biology, CAS

Chinese Academy of Sciences

研究点 (1)

Loading locations...

相似试验